AzTrials
AzTrials

Menopausal ComplaintsNCT06755255

Evaluation of the Relationship Between Mediterranean Diet and Menopausal Symptoms in Postmenopausal Women

An observational study of Menopausal Complaints, run by Marmara University Pendik Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This cross-sectional study aimed to evaluate the relationship between the frequency and severity of postmenopausal symptoms in women aged 45-65 years and the level of compliance with the Mediterranean diet, and the main question it aimed to answer is: Do women with higher compliance with the Mediterranean diet have… Read more about this study

Who is it for?
Ages 45 to 65 years, women onlyHealthy volunteers can take part
Conditions the study is for
Menopausal Complaints
How many people
305 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jan 2024to 1 Sep 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 65 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The population of the study consists of all postmenopausal women between the ages of 45-65 registered to Tuzla E-ASM.

Who may be able to join

  • Those who volunteered to participate in the study,

Who cannot join

  • Those with a diagnosed eating disorder,
  • Those using medication for obesity,
  • Those with a chronic metabolic disease that is not receiving treatment and whose values related to the disease are not regulated (pronounced hypo/hyperthyroidism, uncontrolled diabetes, etc.),
  • Those with a mental or physical condition that prevents communication (some neuropsychiatric diseases and mental retardation),
  • Those who do not understand and/or speak Turkish,
  • Those who do not give consent to participate in the study, •-Those who are currently using any hormonal supplements to prevent or reduce menopausal symptoms were excluded from the study.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Marmara University- Tuzla Eğitim ASM

    Istanbul, Tuzla, 34953

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluation of the Relationship Between Mediterranean Diet and Menopausal Symptoms in Postmenopausal Women Aged 45-56

This cross-sectional study aimed to evaluate the relationship between the frequency and severity of postmenopausal symptoms in women aged 45-65 years and the level of compliance with the Mediterranean diet, and the main question it aimed to answer is: Do women with higher compliance with the Mediterranean diet have milder symptoms?

Read the detailed description

This cross-sectional study was conducted between 01.01.2024 and 01.06.2024 with women aged 45-65 who were registered at Tuzla E-ASM affiliated with Marmara University Pendik Hospital and who had been in menopause for at least 1 year. The sample size was calculated as 272 and the target number was determined as 305. After obtaining written consent from the participants who agreed to participate in the study and met the inclusion criteria, a questionnaire form was applied to these individuals, which questioned their sociodemographic characteristics, age of menstruation onset, pregnancy history, smoking and alcohol use, use of supplements, Mediterranean Diet Adherence Scale (MEDAS) and Menopause Rating Scale (MRS). The presence, type and severity of menopausal symptoms with the Mediterranean diet were evaluated.

Keywords
Menopausal Complaints, climacteric, menopausal symptoms, mediterranean diet

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06755255
Study groupRoleWhat they receive
postmenopausal women aged 45-65Women who were registered at Tuzla E-ASM affiliated with Marmara University Pendik Hospital and who had been in menopause for at least 1 year

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mediterranean diet adherence and menopausal symptoms association

    Mediterranean diet adherence total score and menopausal rating scale total score were inversely and weakly correlated with each other (p<0.01; r= -0.295).

    Measured: Data collected at a single time point upon participants' enrollment.

Secondary outcomes (4)
  1. Menopausal symptom severity in women with low and dietary adherence

    Women with mild menopausal symptoms had the highest adherence score with the Mediterranean diet, while women with severe symptoms had the lowest adherence score to the Mediterranean diet (p<0.01).

    Measured: Data collected at a single time point upon participants' enrollment.

  2. Vasomotor menopausal symptom severity in women with low dietary compliance

    Mediterranean diet adherence scores were lower in the group with severe vasomotor symptoms. (p<0,05)

    Measured: Data collected at a single time point upon participants' enrollment.

  3. Psychological menopausal symptom severity in women with low dietary compliance

    Mediterranean diet adherence scores were lower in the group with severe psychological symptoms.

    Measured: Data collected at a single time point upon participants' enrollment.

  4. Urogenital menopausal symptom severity in women with low dietary compliance

    There is no significant relationship between urogenital symptom scores and Mediterranean diet compliance scores.

    Measured: Data collected at a single time point upon participants' enrollment.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jan 2025
  2. Study start1 Jan 2024
  3. Primary completion1 Aug 2024
  4. Study completion1 Sep 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
305 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06755255
Sponsor's protocol ID
09.2023.1767
Status last verified
Nov 2024
First submitted
19 Nov 2024
Last updated
1 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Participant's survey forms

Publications

  • Ö. Can Gürkan and M. A. Hemşirelik Yüksekokulu Kadın Sağlığı ve Hastalıkları Hemşireliği Araştırma Görevlisi, "MENOPOZ SEMPTOMLARI DEĞERLENDİRME ÖLÇEĞİNİN TÜRKÇE FORMUNUN GÜVENİRLİK VE GEÇERLİLİĞİ."

  • E. Fatma et al., "Turkish Validation and Reliability of Mediterranean Diet Adherence Screener," Pehlivanoglu Ozkan EF. Balcioglu H. Unluoglu I, vol. 42, no. 2, pp. 160-164, 2020, doi: 10.20515/otd.

  • Byrne-Kirk M, Mantzioris E, Scannell N, Villani A. Adherence to a Mediterranean-style diet and severity of menopausal symptoms in perimenopausal and menopausal women from Australia: a cross-sectional analysis. Eur J Nutr. 2024 Oct;63(7):2743-2751. doi: 10.1007/s00394-024-03462-3. Epub 2024 Jul 18.

    PubMed 39026104
  • Herber-Gast GC, Mishra GD. Fruit, Mediterranean-style, and high-fat and -sugar diets are associated with the risk of night sweats and hot flushes in midlife: results from a prospective cohort study. Am J Clin Nutr. 2013 May;97(5):1092-9. doi: 10.3945/ajcn.112.049965. Epub 2013 Apr 3.

    PubMed 23553160
  • Vetrani C, Barrea L, Rispoli R, Verde L, De Alteriis G, Docimo A, Auriemma RS, Colao A, Savastano S, Muscogiuri G. Mediterranean Diet: What Are the Consequences for Menopause? Front Endocrinol (Lausanne). 2022 Apr 25;13:886824. doi: 10.3389/fendo.2022.886824. eCollection 2022.

    PubMed 35546996
  • L. Barrea, G. Pugliese, D. Laudisio, S. Savastano, A. Colao, and G. Muscogiuri, "Does Mediterranean diet could have a role on age at menopause and in the management of vasomotor menopausal symptoms? The viewpoint of the endocrinological nutritionist," 2021. doi: 10.1016/j.cofs.2021.02.018.

Questions about this trial

What is this clinical trial studying?

An observational study of Menopausal Complaints, run by Marmara University Pendik Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mediterranean diet adherence and menopausal symptoms association (time frame: Data collected at a single time point upon participants' enrollment.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06755255, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in